AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer
BioSpace
Cancer cocktails pairing Moderna's mRNA-4359 with Merck's Keytruda and Marengo's invikafusp alfa with Gilead Sciences' Trodelvy showed promising results, while a complex combination by Agenus and MiNK
pharminent
April 28, 2026 (Last updated: April 28, 2026)
BioSpace
Cancer cocktails pairing Moderna’s mRNA-4359 with Merck’s Keytruda and Marengo’s invikafusp alfa with Gilead Sciences’ Trodelvy showed promising results, while a complex combination by Agenus and MiNK
